{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:08:38Z","timestamp":1792069718449,"version":"4.4.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,4]]},"DOI":"10.18632\/oncotarget.17871","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T15:14:38Z","timestamp":1495638878000},"page":"44312-44325","source":"Crossref","is-referenced-by-count":84,"title":["The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Shingo","family":"Tayama","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Motohara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashdemberel","family":"Narantuya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Maternal-Newborn Nursing, Kumamoto University, Chuo-Ku, Kumamoto 860-0976, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[{"name":"Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Shinjuku-Ku, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Nagano","sequence":"additional","affiliation":[{"name":"Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Shinjuku-Ku, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Katabuchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Chuo-Ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Mills","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccell.2016.06.020","article-title":"Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche","volume":"30","author":"Jiang","year":"2016","journal-title":"Cancer Cell"},{"key":"3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Kaye","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond chemotherapy: targeted therapies in ovarian cancer","volume":"9","author":"Kaye","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Kaye","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Weissman","year":"2001","journal-title":"Nature"},{"key":"7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Lindeman","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.201202014","article-title":"The evolving concept of cancer and metastasis stem cells","volume":"198","author":"Trumpp","year":"2012","journal-title":"J Cell Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth","volume":"19","author":"Ishikawa","year":"2011","journal-title":"Cancer Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ncomms1892","article-title":"Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell","volume":"3","author":"Minami","year":"2012","journal-title":"Nat Commun"},{"key":"11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/AOG.0000000000001420","article-title":"CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer","volume":"127","author":"Katabuchi","year":"2016","journal-title":"Obstet Gynecol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/cas.12765","article-title":"CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer","volume":"106","author":"Katabuchi","year":"2015","journal-title":"Cancer Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ncb1824","article-title":"Nuclear signalling by tumour-associated antigen EpCAM","volume":"11","author":"Gires","year":"2009","journal-title":"Nat Cell Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/carcin\/bgq187","article-title":"EpCAM in carcinogenesis: the good, the bad or the ugly","volume":"31","author":"Rots","year":"2010","journal-title":"Carcinogenesis"},{"key":"15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.76.3.1438","article-title":"Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies","volume":"76","author":"Koprowski","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.stem.2014.04.010","article-title":"Stem\/progenitor cells in liver development, homeostasis, regeneration, and reprogramming","volume":"14","author":"Itoh","year":"2014","journal-title":"Cell Stem Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.bjc.6602924","article-title":"Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers","volume":"94","author":"Baeuerle","year":"2006","journal-title":"Br J Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2006.03.035","article-title":"Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer","volume":"103","author":"Zeimet","year":"2006","journal-title":"Gynecol Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2013.11.093","article-title":"EpCAM expression in the prostate cancer makes the difference in the response to growth factors","volume":"443","author":"Saya","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"20","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.0703478104","article-title":"Phenotypic characterization of human colorectal cancer stem cells","volume":"104","author":"Castelli","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"21","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Clarke","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features","volume":"136","author":"Honda","year":"2009","journal-title":"Gastroenterology"},{"key":"23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Simeone","year":"2007","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/bgr183","article-title":"Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells","volume":"32","author":"Nagano","year":"2011","journal-title":"Carcinogenesis"},{"key":"25","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.biocel.2013.09.008","article-title":"Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo\/radioresistance via the PI3K\/Akt\/mTOR signaling pathway","volume":"45","author":"Li","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/IGC.0b013e3181a8331f","article-title":"Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent\/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy","volume":"19","author":"Santin","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1038\/sj.onc.1206394","article-title":"HER2\/PI-3K\/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells","volume":"22","author":"Fan","year":"2003","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3802\/jgo.2014.25.3.221","article-title":"Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer","volume":"25","author":"Sehouli","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.humpath.2008.10.013","article-title":"Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma","volume":"40","author":"Cho","year":"2009","journal-title":"Hum Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.18632\/oncotarget.6870","article-title":"Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4\/HH signaling loop","volume":"9","author":"Buckanovich","year":"2016","journal-title":"Oncotarget"},{"key":"32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/138920371604150429151457","article-title":"Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance","volume":"16","author":"Han","year":"2015","journal-title":"Curr Protein Pept Sci"},{"key":"33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcb.24317","article-title":"Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance","volume":"114","author":"Quinn","year":"2013","journal-title":"J Cell Biochem"},{"key":"34","doi-asserted-by":"crossref","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","article-title":"Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism","volume":"9","author":"Odunsi","year":"2014","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s001099900038","article-title":"The biology of the 17-1A antigen (Ep-CAM)","volume":"77","author":"Litvinov","year":"1999","journal-title":"J Mol Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Lindeman","year":"2012","journal-title":"Cell Stem Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"38","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(00)03312-2","article-title":"Ep-CAM overexpression in breast cancer as a predictor of survival","volume":"356","author":"Mikuz","year":"2000","journal-title":"Lancet"},{"key":"39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jcp.2007.049460","article-title":"EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder","volume":"61","author":"Ensinger","year":"2008","journal-title":"J Clin Pathol"},{"key":"40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ctrv.2010.03.001","article-title":"Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy","volume":"36","author":"Bokemeyer","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/mabs.2.2.11221","article-title":"Catumaxomab: clinical development and future directions","volume":"2","author":"Seimetz","year":"2010","journal-title":"MAbs"},{"key":"42","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/ijc.26258","article-title":"Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II\/III study in patients with malignant ascites","volume":"130","author":"Seimetz","year":"2012","journal-title":"Int J Cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","article-title":"The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II\/III trial","volume":"127","author":"Wimberger","year":"2010","journal-title":"Int J Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-11-2235","article-title":"Immunomonitoring results of a phase II\/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)","volume":"72","author":"Lindhofer","year":"2012","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1517\/14712598.2010.482098","article-title":"Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside","volume":"10","author":"Dufour","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-11-1270","article-title":"EpCAM\/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells","volume":"18","author":"Heeschen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"47","volume-title":"Pathlogy and Genetics of Tumours of the Breast and Female Genital Organs","author":"Devilee","year":"2003"},{"key":"48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","article-title":"Carcinoma of the ovary","volume":"83","author":"Pecorelli","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"49","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1349-7006.2010.01556.x","article-title":"Long-term oncological outcomes of ovarian serous carcinomas with psammoma bodies: a novel insight into the molecular pathogenesis of ovarian epithelial carcinoma","volume":"101","author":"Katabuchi","year":"2010","journal-title":"Cancer Sci"},{"key":"50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Dodd","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T09:37:17Z","timestamp":1719221837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":50,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,7,4]]}},"alternative-id":["17871","28574829"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17871","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}